Dana E. Moseson - Concepedia

Author

Dana E. Moseson

Purdue University West Lafayette ORCID

Also Known As

Dana E. Moseson, Dana Moseson, Moseson, Dana

Publications

979

Citations

H-Index

Concepts

All Affiliations

Purdue University West Lafayette KU Leuven Eli Lilly (United States)Merck & Co., Inc., Rahway, NJ, USA (United States)Applied Materials (United States)

About

Dana E. Moseson is an author at Purdue University West Lafayette specializing in engineering, materials science, and polymer chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	13	14	652
2	Medicine	4	4	180
3	Applied Physics	3	3	135
4	Biomedical Engineering	2	2	115
5	Biochemistry	1	1	13

Dana E. Moseson

Publications

895

Citations

H-Index

Page 1

	Year	Citations
High volume limestone alkali-activated cement developed by design of experiment Alexander J. Moseson, Dana E. Moseson, Michel W. Barsoum Cement and Concrete Composites CementationEngineeringCivil EngineeringCementitious MaterialsHigh Volume	2011	102
Patterns of drug release as a function of drug loading from amorphous solid dispersions: A comparison of five different polymers. Sugandha Saboo, Dana E. Moseson, Umesh S. Kestur, European Journal of Pharmaceutical Sciences Different PolymersEngineeringMedicinePolymer ScienceDrug Delivery Systems	2020	90
The application of temperature-composition phase diagrams for hot melt extrusion processing of amorphous solid dispersions to prevent residual crystallinity Dana E. Moseson, Lynne S. Taylor International Journal of Pharmaceutics Materials ScienceEngineeringTemperature-composition Phase DiagramsResidual CrystallinityApplied Physics	2018	86
Application and limitations of thermogravimetric analysis to delineate the hot melt extrusion chemical stability processing window Dana E. Moseson, M. Jordan, Dishan D. Shah, International Journal of Pharmaceutics Materials ScienceThermogravimetric AnalysisEngineeringDerivative ThermogravimetryHot Working	2020	67
Exploring the Role of Surfactants in Enhancing Drug Release from Amorphous Solid Dispersions at Higher Drug Loadings Sugandha Saboo, Pradnya Bapat, Dana E. Moseson, Pharmaceutics	2021	65
Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023 Dana E. Moseson, Tran Trong Bien, Bharathi Karunakaran, International Journal of Pharmaceutics X	2024	63
Amorphous solid dispersions containing residual crystallinity: Influence of seed properties and polymer adsorption on dissolution performance Dana E. Moseson, Andrew S. Parker, Stephen P. Beaudoin, European Journal of Pharmaceutical Sciences Materials ScienceEngineeringResidual CrystallinityPolymer SciencePolymer Adsorption	2020	58
Interplay of Supersaturation and Solubilization: Lack of Correlation between Concentration-Based Supersaturation Measurements and Membrane Transport Rates in Simulated and Aspirated Human Fluids Ahmed Elkhabaz, Dana E. Moseson, Joachim Brouwers, Molecular Pharmaceutics Pharmaceutical ScienceEngineeringDifferent MediaMembrane TransportBioanalysis	2019	55
Amorphous Solid Dispersions Containing Residual Crystallinity: Competition Between Dissolution and Matrix Crystallization Dana E. Moseson, Isaac D. Corum, Andres Lust, The AAPS Journal Materials ScienceMatrix CrystallizationEngineeringCompetition Between DissolutionChemistry	2021	47
Effect of Polymer Species on Maximum Aqueous Phase Supersaturation Revealed by Quantitative Nuclear Magnetic Resonance Spectroscopy Keisuke Ueda, Dana E. Moseson, Vaibhav Pathak, Molecular Pharmaceutics	2021	29

Page 1